Table 2 The variables in the multivariate analysis for the BCLC-B stage.

From: Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma

All included patients (n = 1464)

HIV(+) patients(n = 21)

Variables

Relative risk (95% CI)

P

Variables

Relative risk (95% CI)

P

Child–Pugh score (mean ± SD)

1.250 (1.129–1.384)

 < 0.001

Plt

0.983 (0.968–0.999)

0.038

WBC (mean ± SD ,109/L)

1.106 (1.065–1.149)

 < 0.001

ALT

0.966 (0.934–0.999)

0.043

AST mean ± SD, u/L)

1.002 (1.001–1.002)

 < 0.001

Tumor size (mean ± SD , cm)

4.009 (1.468–10.948)

0.007

Serum AFP > 400 ng/mL

1.499 (1.293–1.739)

 < 0.001

Tumor size (mean ± SD , cm)

1.050 (1.031–1.069)

 < 0.001

TACE (+)

0.480 (0.392–0.588)

 < 0.001

  1. The variables of P < 0.1 in single factor analysis were included in multivariate analysis.
  2. Plt platelet, Alb albumin; AST aspartate aminotransferase; ALT alanine aminotransferase, AFP alpha-fetoprotein, WBC white blood cell.
Back to article page